Cite
HARVARD Citation
Prescott, E. et al. (2022). Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study. International journal of cardiology. pp. 34-40. [Online].